Your browser doesn't support javascript.
loading
Potential of Novel Methyl Jasmonate Analogs as Anticancer Agents to Metabolically Target HK-2 Activity in Glioblastoma Cells.
Uludag, Damla; Bay, Sadik; Sucu, Bilgesu Onur; Savlug Ipek, Özgecan; Mohr, Thomas; Güzel, Mustafa; Karakas, Nihal.
  • Uludag D; Cancer Research Center, Research Institute for Health Sciences and Technologies (SABITA), Istanbul Medipol University, Istanbul, Turkey.
  • Bay S; Regenerative and Restorative Medicine Research Center (REMER), Research Institute for Health Sciences and Technologies (SABITA), Istanbul Medipol University, Istanbul, Turkey.
  • Sucu BO; Center of Drug Discovery and Development, Research Institute for Health Sciences and Technologies (SABITA), Istanbul Medipol University, Istanbul, Turkey.
  • Savlug Ipek Ö; Medical Laboratory Techniques, Vocational School of Health Services, Istanbul Medipol University, Istanbul, Turkey.
  • Mohr T; Center of Drug Discovery and Development, Research Institute for Health Sciences and Technologies (SABITA), Istanbul Medipol University, Istanbul, Turkey.
  • Güzel M; Center for Cancer Research, Medical University of Vienna, Vienna, Austria.
  • Karakas N; ScienceConsult-DI Thomas Mohr KG, Vienna, Austria.
Front Pharmacol ; 13: 828400, 2022.
Article en En | MEDLINE | ID: mdl-35677429
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies Idioma: En Año: 2022 Tipo del documento: Article